Orrick and Advokatfirmaet CLP advised D2L on the deal. D2L Inc., a global learning technology company based in Ontario, Canada, is acquiring H5P Group, a leading...
You must be a Standard 1 Year member to access this content.
Fenwick & West represented Royalty Pharma, and Orrick Herrington & Sutcliffe represented Ferring Pharmaceuticals in the deal. Royalty Pharma plc (Nasdaq: RPRX) and Ferring Pharmaceuticals announced...
You must be a Standard 1 Year member to access this content.
Orrick advised Sosei Heptares. Sosei Heptares has announced its acquisition for U.S.$466 million (JPY 65 billion) of Idorsia’s pharmaceuticals business in Japan and APAC (ex-China). Sosei...
You must be a Standard 1 Year member to access this content.
Orrick advised RapidMiner on the deal. RapidMiner, a data analytics and machine learning software company, announced its acquisition by Altair Engineering (Nasdaq: ALTR), a global leader in...
You must be a Standard 1 Year member to access this content.
Orrick advised Catalyst Biosciences, Inc. on the deal. South San Francisco-based biopharmaceutical company Catalyst Biosciences, Inc. (NASDAQ: CBIO) announced the sale of its complement asset portfolio for...
You must be a Standard 1 Year member to access this content.
Kirkland & Ellis advised funds and other accounts managed by Ares Management Corp., while Orrick advised Apex Clean Energy. Apex Clean Energy (“Apex”) and Ares Management...
You must be a Standard 1 Year member to access this content.
Orrick Herrington & Sutcliffe LLP advised Aria Energy on the deal while Pillsbury Winthrop Shaw Pittman LLP represented Archaea Energy LLC. Kirkland & Ellis advised Rice...
You must be a Standard 1 Year member to access this content.
